With several smaller drug and biotech companies still to report fourth-quarter earnings, today’s article highlights four which are expected to deliver earnings surprises in their… Read More »4 Drug/Biotech Stocks Set To Deliver Earnings Surprises
Today’s article highlights three stocks that have the potential to double “if things go right”. To find out what these three stocks are – a… Read More »3 Stocks To Consider Buying On The ‘Double’
Donald Trump doesn’t like losers – but investors may be well served by focusing on areas of the stock market that have not gotten swept… Read More »The Biggest Trump Rally Losers – And The Contrarian Case For Buying Them
Today’s article acknowledges that the bad publicity generated by several high-profile drug price controversies – with the most recent involving Mylan and its EpiPen –… Read More »What To Do About Healthcare Stocks
“It’s probably best to forget Valeant and instead invest in some other drug stocks,” argues today’s article. For investors looking for drug stocks but who… Read More »4 Drug Stocks For The Valeant-Averse